TC
DRTX

TFS Capital’s DURATA THERAPEUTICS INC COM STK (DE) DRTX Stock Holding History

TFS Capital’s Portfolio DRTX Stock Details DRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-25,976
Closed -$350K – 1586
2014
Q1 		$350K Buy
+25,976
New +$340K 0.02% 927

Other funds holding DRTX

AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CPV
Canaan Partners VII Westport, Connecticut $32.3M AUM 154.97% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TFS Capital's DRTX Position: Q2 2014 in Review

TFS Capital sold out of DURATA THERAPEUTICS INC COM STK (DE) (DRTX) in Q2 2014, closing a stake of 25,976 shares — an estimated $350K sold.

TFS Capital first reported a position in DRTX in Q1 2014 and held it in 1 quarter. The position peaked at $350K in Q1 2014. 74 funds tracked by Wall St. Rank hold DRTX as of Q2 2014.

  • TFS Capital reported no remaining DURATA THERAPEUTICS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • TFS Capital sold 25,976 DURATA THERAPEUTICS INC COM STK (DE) shares in Q2 2014, an estimated $350K.
  • TFS Capital first reported a position in DURATA THERAPEUTICS INC COM STK (DE) in Q1 2014 and held it in 1 quarter.
  • TFS Capital's DURATA THERAPEUTICS INC COM STK (DE) position peaked at $350K in Q1 2014.
  • 74 funds tracked by Wall St. Rank held DURATA THERAPEUTICS INC COM STK (DE) as of Q2 2014.

Based on TFS Capital's 13F filing for Q2 2014, filed 21 Jul 2014.